PL2268308T5 - Szczepionka ochronna przeciwko lawsonia intracellularis - Google Patents

Szczepionka ochronna przeciwko lawsonia intracellularis

Info

Publication number
PL2268308T5
PL2268308T5 PL09753743.5T PL09753743T PL2268308T5 PL 2268308 T5 PL2268308 T5 PL 2268308T5 PL 09753743 T PL09753743 T PL 09753743T PL 2268308 T5 PL2268308 T5 PL 2268308T5
Authority
PL
Poland
Prior art keywords
vaccine
protection against
against lawsonia
lawsonia intracellulars
intracellulars
Prior art date
Application number
PL09753743.5T
Other languages
English (en)
Other versions
PL2268308T3 (pl
Inventor
Antonius Arnoldus Christiaan Jacobs
Paul Vermeij
Ruud Philip Antoon Maria Segers
Carla Christina Schrier
Original Assignee
Intervet International B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41212183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2268308(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International B.V. filed Critical Intervet International B.V.
Publication of PL2268308T3 publication Critical patent/PL2268308T3/pl
Publication of PL2268308T5 publication Critical patent/PL2268308T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL09753743.5T 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis PL2268308T5 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US4616108P 2008-04-18 2008-04-18
EP08154764 2008-04-18
US11175608P 2008-11-06 2008-11-06
EP08105738 2008-11-06
EP09753743.5A EP2268308B2 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellulars
PCT/EP2009/054516 WO2009144088A2 (en) 2008-04-18 2009-04-16 Vaccine for protection against lawsonia intracellulars

Publications (2)

Publication Number Publication Date
PL2268308T3 PL2268308T3 (pl) 2018-07-31
PL2268308T5 true PL2268308T5 (pl) 2026-08-10

Family

ID=41212183

Family Applications (2)

Application Number Title Priority Date Filing Date
PL09753743.5T PL2268308T5 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis
PL18154850T PL3351267T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL18154850T PL3351267T3 (pl) 2008-04-18 2009-04-16 Szczepionka ochronna przeciwko lawsonia intracellularis

Country Status (12)

Country Link
US (3) US20110033496A1 (pl)
EP (3) EP3351267B1 (pl)
JP (2) JP6026106B2 (pl)
CN (1) CN102006883A (pl)
BR (1) BR122019000869B1 (pl)
CA (1) CA2717969C (pl)
DK (2) DK3351267T3 (pl)
FR (1) FR21C1002I1 (pl)
HU (2) HUE038294T2 (pl)
PL (2) PL2268308T5 (pl)
TW (1) TWI551295B (pl)
WO (1) WO2009144088A2 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
EP2499233B1 (en) 2009-11-09 2016-11-02 Intervet International B.V. Method to grow lawsonia intracellularis bacteria in persistently infected mccoy cells
KR101837768B1 (ko) 2011-05-25 2018-03-12 건국대학교 산학협력단 돼지 증식성 회장염을 진단하기 위한 단백질 및 그 응용
PL3076996T3 (pl) 2013-12-03 2020-05-18 Intervet International B.V. Szczepionka przeciwko cirkowirusowi świń typu 2
KR102360690B1 (ko) * 2013-12-03 2022-02-08 인터벳 인터내셔널 비.브이. Ｐｒｒｓ 및 로소니아 인트라셀룰라리스에 대한 돼지 백신
WO2015082457A1 (en) 2013-12-03 2015-06-11 Intervet International B.V. Vaccine against lawsonia intracellularis and porcine circovirus 2
JP2018504424A (ja) * 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
US10265392B2 (en) 2015-02-04 2019-04-23 Intervet Inc. Vaccine for use against subclinical Lawsonia infection in a pig
DK3365001T3 (da) * 2015-10-22 2022-08-22 Intervet Int Bv Vaccine til at beskytte et mda-positivt dyr mod en lidelse, der udspringer af en infektion med lawsonia intracellularis
JP6655414B2 (ja) 2016-02-15 2020-02-26 株式会社デンソー 排気浄化システム
JP7354106B2 (ja) 2017-12-04 2023-10-02 インターベット インターナショナル ベー． フェー． レプリコン粒子および油性アジュバントによるワクチン接種
EP3727444A1 (en) 2017-12-18 2020-10-28 Intervet International B.V. Swine influenza a virus vaccine
MX2020008913A (es) 2018-02-28 2020-10-01 Boehringer Ingelheim Vetmedica Gmbh Metodo para reducir el escatol y/o indol en animales.
WO2021255221A1 (en) 2020-06-19 2021-12-23 Intervet International B.V. Swine influenza a virus vaccine comprising a nucleic acid construct encoding antigens of specific virus lineages
EP4168041A1 (en) 2020-06-19 2023-04-26 Intervet International B.V. Swine influenza a virus vaccine comprising a nucleic acid construct having a specific order of genes
US20230248817A1 (en) 2020-06-19 2023-08-10 Intervet Inc. Swine influenza a virus vaccine comprising a nucleic acid construct comprising first, second and third nucleic acid sequences encoding distinct neuraminidase antigens of the virus
EP4168044A1 (en) 2020-06-19 2023-04-26 Intervet International B.V. Swine influenza a virus vaccine comprising two distinct rna replicon particles
US20250281597A1 (en) 2021-10-25 2025-09-11 Intervet Inc. A vaccine for the protection of piglets against swine influenza a virus infection
EP4426342A1 (en) 2021-11-01 2024-09-11 Boehringer Ingelheim Vetmedica GmbH Immunogenic gel compositions
EP4594466A1 (en) 2022-09-27 2025-08-06 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
WO2024260953A1 (en) 2023-06-23 2024-12-26 Intervet International B.V. A method of culturing lawsonia intracellularis bacteria
WO2025262123A1 (en) 2024-06-19 2025-12-26 Intervet International B.V. Veterinary vaccines against enteric diseases
WO2025262124A1 (en) 2024-06-19 2025-12-26 Intervet International B.V. Adjuvanted veterinary vaccines against enteric diseases

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE115862T1 (de) 1989-02-04 1995-01-15 Akzo Nobel Nv Tocole als impfstoffadjuvans.
FR2649012B1 (fr) 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
JP2000502054A (ja) * 1995-11-30 2000-02-22 アグリカルチャー ビクトリア サービシーズ ピーティーワイ．エルティーディー． 治療用および診断用の組成物
WO2000069906A1 (en) * 1999-05-13 2000-11-23 Pfizer Products Inc Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
EP1094070A3 (en) 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis proteins, and related methods and materials
WO2002026250A2 (en) 2000-09-29 2002-04-04 Arizona Board Of Regents On Behalf Of The University Of Arizona Vaccines for proliferative ileitis
EP1219711B1 (en) 2000-12-20 2006-06-14 Intervet International BV Lawsonia intracellularis vaccine
CA2533559C (en) * 2003-07-25 2013-07-02 Boehringer Ingelheim Vetmedica, Inc. Lawsonia intracellularis of european origin and vaccines, diagnostic agents and methods of use thereof
EP1709067B1 (en) 2004-01-22 2010-06-09 Intervet International BV Lawsonia intracellularis subunit vaccines
KR20110132416A (ko) * 2004-04-05 2011-12-07 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
ES2730275T3 (es) * 2004-09-22 2019-11-11 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos
US20070212373A1 (en) 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
CN101277717A (zh) 2005-09-09 2008-10-01 英特威国际有限公司 Pcv-2疫苗
JP2009528361A (ja) 2006-03-03 2009-08-06 メリアル リミテッド マイコプラズマ・ハイオニューモニエワクチン
NZ570805A (en) * 2006-03-30 2011-10-28 Glaxosmithkline Biolog Sa Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
KR101358517B1 (ko) 2006-04-10 2014-02-06 인터벳 인터내셔널 비.브이. 마이코플라즈마 ｐｒｒｓｖ에 대한 백신
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
MX2008015164A (es) 2006-05-30 2008-12-12 Intervet Int Bv Vacuna contra organismos de tipo rickettsia.
TWI551295B (zh) * 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗
JP2018504424A (ja) 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン

Also Published As

Publication number Publication date
US8597662B2 (en) 2013-12-03
EP2268308B2 (en) 2026-05-06
CA2717969C (en) 2016-06-07
US20130302372A1 (en) 2013-11-14
EP2268308A2 (en) 2011-01-05
JP6138875B2 (ja) 2017-05-31
EP3351267B1 (en) 2020-08-05
PL3351267T3 (pl) 2020-11-30
PL2268308T3 (pl) 2018-07-31
US9198963B2 (en) 2015-12-01
DK2268308T4 (da) 2026-06-29
CN102006883A (zh) 2011-04-06
DK2268308T3 (en) 2018-05-22
JP2011516600A (ja) 2011-05-26
TWI551295B (zh) 2016-10-01
FR21C1002I1 (fr) 2021-03-05
US20130045228A1 (en) 2013-02-21
WO2009144088A2 (en) 2009-12-03
WO2009144088A3 (en) 2010-05-06
EP3351267A1 (en) 2018-07-25
JP6026106B2 (ja) 2016-11-16
JP2016026154A (ja) 2016-02-12
HUE038294T2 (hu) 2018-10-29
TW201002342A (en) 2010-01-16
BR122019000869B1 (pt) 2023-11-07
US20110033496A1 (en) 2011-02-10
HUS2000047I1 (hu) 2020-12-28
CA2717969A1 (en) 2009-12-03
BRPI0909769A2 (pt) 2015-08-11
DK3351267T3 (da) 2020-09-21
EP3708186A1 (en) 2020-09-16
EP2268308B1 (en) 2018-03-14